Manchester Pharmaceuticals

Retrophin Inc. will have a new drug to commercialize as it moves beyond a controversial management shakeup last year and focuses on the business development-focused strategy put in place by its new

Financings During the first quarter of 2014 start-up companies raised $1.18 billion, up $2.8 million from last quarter’s impressive total and setting a new record for start-up fundraising since we beg

IN VITRO DIAGNOSTICS Mergers & Acquisitions Becton Dickinson & Co. Alverix Inc. Becton Dickinson & Co. acquired its privately held point-of-care testing partner Alverix Inc. (optoelectronics)

Neither MedImmune LLC , the biologics arm of AstraZeneca PLC , nor the University of California, San Francisco , is a stranger to R&D collaboration between private industry and academia. But